Year: 2023

Hist_Logo_W

HiST Pharma Announces U.S. FDA Approval to Initiate Phase III Clinical Study With TC Cream – World’s First Botanical Small-Molecule Drug That Treats Psoriasis Vulgaris

GUANGZHOU, China--(BUSINESS WIRE)--HiST Pharma through its wholly-owned Psoriasis Research Institute of Guangzhou (PRIG) announces today that the U.S. Food and...

logo-50

Quectel Breaks Ground for New Innovation Headquarters and Readies for Aggressive Growth Plans With Opening of Most Advanced Smart Factory

SHANGHAI--(BUSINESS WIRE)--#5G--Quectel Wireless Solutions, a global IoT solutions provider, today announces breaking ground for its new innovation Headquarter in Shanghai...